Cancer news from the American Cancer Society.
Published on: April 29, 2020
The US Food and Drug Administration (FDA) approved a new type of therapy for triple-negative breast cancer that has spread to other parts of the body and hasn’t responded to other treatments.
Published on: January 23, 2020
Taking certain supplements while undergoing chemotherapy for breast cancer may do more harm than good. A small study found that patients who took antioxidants had higher chances of cancer recurrence and death.
Published on: December 6, 2019
An observational study from researchers at the National Institute of Health (NIH) found that women who used permanent hair dye and chemical hair straighteners had a higher risk of breast cancer than women who didn’t use them.
Published on: July 25, 2019
The pharmaceutical company Allergan has recalled all BioCell textured breast implants at the request of the US Food and Drug Administration (FDA) because they have been linked to a rare type of lymphoma.
Published on: May 29, 2019
The US Food and Drug Administration (FDA) has approved the first treatment of its kind for a certain type of breast cancer caused by an inherited genetic mutation. Piqray (alpelisib) is a targeted therapy called a PI3K inhibitor.